Skip to content
Visionary Ventures
Venture capital fund investing life sciences focusing in ophthalmology medical devices and pharmaceuticals.
Visionary VenturesVisionary Ventures
  • HOME
  • OPHTHALMOLOGY FUND
  • Visionary KOLs
  • TEAM
    • Investment Committee
    • Fund Management
  • PORTFOLIO
  • NEWS
  • CONTACT
  •  INVESTOR LOGIN
Fund Menu
Search
  • HOME
  • OPHTHALMOLOGY FUND
  • Visionary KOLs
  • TEAM
    • Investment Committee
    • Fund Management
  • PORTFOLIO
  • NEWS
  • CONTACT
  •  INVESTOR LOGIN

Monthly Archives: October 2018

Carl Zeiss Meditec to Acquire Visionary Portfolio company IanTECH

Acquisition, IanTECH, NewsBy Garrett HamontreeOctober 23, 2018

Zeiss acquires Visionary portfolio company IanTECH to expand its portfolio in cataract surgery.

Visionary Managing Partner, Jeffry Weinhuff, Appointed to Chairman of Orasis

News, OrasisBy Garrett HamontreeOctober 22, 2018

Orasis announces the Appointment of Jeffry Weinhuff as Chairman of the Board of Directors.

Orasis CEO, Elad Kedar, Interviewed at OIS and AAO

News, OrasisBy Garrett HamontreeOctober 20, 2018

Elad Kedar discusses the presbyopia market and the Orasis product.

Ophthalmology Management Article on “Partnering for Innovation”

News, VisionaryBy Garrett HamontreeOctober 1, 2018

Jeffry Weinhuff, discusses how ophthalmologists, entrepreneurs, strategic buyers, and venture capitalists partner for success.

  • Home
  • Ophthalmology
  • Team
    • Investment Committee
    • Visionary KOLs
    • Fund Management
  • Portfolio
  • News
  • Contact
  • Investor Portal
Footer Menu

© 2019 Visionary Ventures. All Rights Reserved.

Go to Top